Cardiovascular Magnetic Resonance for Rejection Surveillance after Cardiac Transplantation
Traditionally, endomyocardial biopsy has been used as the gold standard for monitoring allografts after transplantation. The use of non-invasive alternatives, however, would be safer for patients if they were proven to be as effective or more effective at identifying rejection. In this presentation, we discuss the potential utility of cardiac MRI in this context.
Join the conversation on Twitter:
https://twitter.com/YaleHF
Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation:
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057006
Видео Cardiovascular Magnetic Resonance for Rejection Surveillance after Cardiac Transplantation канала Yale Cardiovascular Medicine Grand Rounds
Join the conversation on Twitter:
https://twitter.com/YaleHF
Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation:
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057006
Видео Cardiovascular Magnetic Resonance for Rejection Surveillance after Cardiac Transplantation канала Yale Cardiovascular Medicine Grand Rounds
Показать
Комментарии отсутствуют
Информация о видео
13 декабря 2022 г. 4:56:56
00:36:32
Другие видео канала
![Rehospitalization of Patients with AHF Receiving Continuous Palliative Dobutamine or Milrinone](https://i.ytimg.com/vi/BtKBIlAKZXg/default.jpg)
![Using Mouse Models to Understand Disease Mechanism: Lessons From Cavernous Malformation and COVID-19](https://i.ytimg.com/vi/L0-TuI6nenE/default.jpg)
![Value and Innovation in Heart Failure: Perspectives from the Health System to the Individual Patient](https://i.ytimg.com/vi/J6U_mHIZgjw/default.jpg)
![Depression, Self-Care, and Rehospitalization in Heart Failure](https://i.ytimg.com/vi/AKOamrM4oU4/default.jpg)
![ITEACH](https://i.ytimg.com/vi/OYA3_XOdAmA/default.jpg)
![YNHHS Transition to High Sensitivity Troponin](https://i.ytimg.com/vi/rw6A22jvaqg/default.jpg)
![Swallowing & Laryngeal Complications following Heart Transplant](https://i.ytimg.com/vi/cBRm6nWf1mY/default.jpg)
![The Genetic Approach to Cardiovascular Diseases, Progress and Challenges](https://i.ytimg.com/vi/FjDY-0HHv8o/default.jpg)
![Immunosuppression and reproductive health](https://i.ytimg.com/vi/X5ibx5CSB2Q/default.jpg)
![IABP Use in Cardiogenic Shock](https://i.ytimg.com/vi/r-WlkXA9Hcw/default.jpg)
![Approach to Antibody Sensitization in Heart Transplantation](https://i.ytimg.com/vi/9Rm39bLKrvQ/default.jpg)
![The Global Burden of Cardiovascular Diseases and Risks](https://i.ytimg.com/vi/CGhTR1y0B1o/default.jpg)
![AHA 2021 Late-Breaking Science](https://i.ytimg.com/vi/1X5YA5_nwCM/default.jpg)
![Hospital to home: strategies to improve outcomes following hospitalization for Heart Failure](https://i.ytimg.com/vi/KPKDhRRv6EY/default.jpg)
![Translational Genomics in Cardiovascular Disease](https://i.ytimg.com/vi/Y4ac2WB6YEI/default.jpg)
![Assessing and Managing Women with Angina: How Are We Doing? Women FiRST Trial: Directions at 1 Year](https://i.ytimg.com/vi/35dVAEV1wUs/default.jpg)
![From Marketing to Medicine: Uplift Modeling to Predict Individual Treatment Effects](https://i.ytimg.com/vi/FH9hJlsZtSg/default.jpg)
![CVM Grand Rounds: Academic Year 2023-2024](https://i.ytimg.com/vi/I6Mhhftc5dY/default.jpg)
![AV Junction Ablation and CRT for Patients with Permanent Afib and Narrow QRS](https://i.ytimg.com/vi/lhsDPRBuzT4/default.jpg)
![Advanced Heart Failure Therapies for Congenital Heart Disease Part 1](https://i.ytimg.com/vi/Zxt5DGl_BN4/default.jpg)